|
Day One: 13 March
2006 |
|
 |
|
|
Registration |
|
|
|
09.15
|
Chairman's
Opening Welcome Address Al Sokol, Partner, Edwards Angell Palmer & Dodge LLP |
|
|
09.30
|
Keynote: The
State of the Industry Dennis Purcell, General Partner, Aisling Capital |
|
|
10.00 |
The Venture Gap between Pharma and Biotech: the Global
Outlook for 2006Chairman: Dr Andrew McDonald, Biotech
Analyst, Think
Equity Panellists: Brian Hargreaves, Sector Partner - Healthcare, 3i Stan Yakatan, Chairman, Katan Associates Jonathan Leff, Managing Director, Warburg Pincus |
|
|
10.45 |
Coffee
Break |
|
|
11.20
|
Company Presentations: Small Cap Listed Companies |
|
|
13.20 |
Lunch |
|
|
14.20 |
Keynote Panel: Investment trends, financing opportunities and challenges in today’s market Chairman: Michael Lytton, General Partner, Oxford Bioscience Partners Panellists: James M Garvey, CEO & Managing Partner, SV Life Science Advisors Dr Steven St. Peter, General Partner, MPM Capital Dr Gert A. Caspritz, General Partner, Techno Venture Management |
|
|
15.30 |
Coffee
Break |
|
|
16.05 |
Company Presentations in Workshops Venture Funded Early to Mid Stage Biotechs • Therapeutics • Immunology/Oncology • Listed Company Presentations |
|
|
18.15 |
Cocktail
Reception |
|
|
Day
Two: 14 March 2006 |
|
|
|
Registration |
|
|
|
| 08.50 |
Opening Welcome |
|
|
09.00 |
New frontiers in Oncology: translational research in oncology Chairman: Dr O Prem Das, Director, Office of Technology Licensing & Industry Sponsored Research, Harvard Medical School Speakers: Dr David Scheinberg, Chairman of the Experimental Therapeutics Center, Memorial Sloan-Kettering Cancer Center Dr Lee Nadler, Senior Vice President for Experimental Medicine, Dana Farber Cancer Institute Mark Chalek, Chief, Business Ventures, Beth Israel Deaconess Medical Center |
|
|
10.15 |
The do’s and don’ts of corporate collaboration:
A practical guide to building and managing a successful alliance. Chairman: Professor Frank Douglas, Professor of Practice, Massachusetts Institute of Technology, Sloan School of Management Panellists: Corinne Savill, Global Head of Search and Evaluation, Business Development and Licensing, Novartis Pharmaceuticals Guy Eiferman, Vice President Alliance Management, Merck & Company Marcia Anderegg, Edwards Angell Palmer & Dodge LLP Phil Tinmouth, Senior Director Corporate Development, Vertex Pharmaceuticals |
|
|
11.00 |
Coffee
Break |
|
|
11.30 |
Attracting new Investment. Innovative business models
for Medtech companies: are we moving towards the Biotech model? Chairman: William C Mills III, Managing Member, EGS Healthcare Capital Partners Panellists: Lothar Krinke, Ph.D., Senior Director Business Development, Medtronic Neurological Tom Sommer, President, MASSMedic Dr Evan Facher, Business Development Manager, MEDRAD, Inc. |
|
|
12.25 |
Lunch |
|
|
13.35 |
Company
Presentations in Workshops Venture Funded Early to Mid Stage Biotechs • Therapeutics • Medtech |
|
|
15.45 |
Close
of Conference |
|
|
To download a pdf version of this agenda click here. |